Early menopause in mothers of children with Down syndrome?

Slides:



Advertisements
Similar presentations
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Advertisements

Electroejaculation as a method of fertility preservation in boys diagnosed with cancer: a single-center experience and review of the literature  Maria.
Outdoor air pollution and human infertility: a systematic review
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Goserelin fosters bone elongation but does not prevent ovarian damage in cyclophosphamide-treated prepubertal mice  Laura Detti, M.D., Rebecca A. Uhlmann,
Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.
Edward G. Hughes, M.B., F.R.C.S.(C.), Deirdre DeJean, M.Sc. 
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Infertility evaluation and treatment among women in the United States
The normal variabilities of the menstrual cycle
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Bjørn Bay, M. D. , Erik Lykke Mortensen, M. Sc
Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis  Annelies Overbeek, Frank J. Broekmans, Wouter.
Michael M. Alper, M.D.  Fertility and Sterility 
Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Patient-tailored ovarian stimulation for in vitro fertilization
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.
Neohormones as biomarkers of reproductive health
"Patient-centered fertility treatment": what is required?
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women  Ellen W. Freeman, Ph.D.,
Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for.
Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy  Ewa Nowak-Markwitz,
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F
Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm.
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Oocyte cryopreservation
Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.
Klinefelter's syndrome with unilateral absence of vas deferens
Chao-Chin Hsu, M. D. , Ph. D. , Hsin-Chih Kuo, Ph. D
Yinghui Ye, M. D. , Ph. D. , Yuqin Luo, B. Sc. , Yuli Qian, B. Sc
Gadolinium radiologic contrast is a useful alternative for hysterosalpingography in patients with iodine allergy  Dorette Noorhasan, M.D., Michael J.
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.
Electroejaculation as a method of fertility preservation in boys diagnosed with cancer: a single-center experience and review of the literature  Maria.
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
Clomiphene citrate at 50: the dawning of assisted reproduction
Introduction Fertility and Sterility
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Results of centralized Asherman surgery, 2003–2013
Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study  Carlo.
Eva Balkenende, Taghride Dahhan, M. D. , Fulco van der Veen, M. D, Ph
Kirstine Kirkegaard, M. D. , Johnny Juhl Hindkjaer, M. Sc
A longitudinal study of the effects of free testosterone and other psychosocial variables on sexual function during the natural traverse of menopause 
Effectiveness of highly purified human menopausal gonadotropin vs
Lindsay M. Mains, M. D. , Babak Vakili, M. D. , Yves Lacassie, M. D
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
Predictive value of basal follicle-stimulating hormone concentrations in a general subfertility population  Joris M van Montfrans, M.D., Annemieke Hoek,
Fertility and Sterility: an evaluation
Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify.
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.
Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss  Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.
Genetic evaluation procedures at sperm banks in the United States
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
In vitro sildenafil citrate use as a sperm motility stimulant
Are urinary bisphenol A levels in men related to semen quality and embryo development after medically assisted reproduction?  Jure Knez, M.D., Roman Kranvogl,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization  Rongrong Tan, M.M.Sc., Danhua Pu,
Presentation transcript:

Early menopause in mothers of children with Down syndrome? Elizabeth M.C. van der Stroom, B.Sc., Tamar E. König, M.D., Eline van Dulmen-den Broeder, Ph.D., Wieteke S. Elzinga, B.Sc., Joris M. van Montfrans, Ph.D., Maaike L. Haadsma, Ph.D., Cornelis B. Lambalk, Ph.D.  Fertility and Sterility  Volume 96, Issue 4, Pages 985-990.e1 (October 2011) DOI: 10.1016/j.fertnstert.2011.07.1149 Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Relationship between antimüllerian hormone (AMH) concentration and highest follicle-stimulating hormone (FSH) concentration of the three cycles (r = –0.588, P<.0001). Fertility and Sterility 2011 96, 985-990.e1DOI: (10.1016/j.fertnstert.2011.07.1149) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Flowchart of patients eligible for analysis of menopause status. Fertility and Sterility 2011 96, 985-990.e1DOI: (10.1016/j.fertnstert.2011.07.1149) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.